420 with CNW — Washington State Supreme Court Repeals Law Criminalizing Drug Possession

The Washington State Supreme Court recently nullified the state’s criminal penalties against drug possession, terming them unconstitutional. This was followed by some prosecutors and police departments in the state announcing that they’d no longer pursue cases of possession or arrest individuals over the possession of small amounts of drugs.

The Seattle Police Department issued a public statement that stated that simple drug possession was no longer deemed to be an arrestable offense, adding that effective immediately, officers in the department would not be arresting persons for merely being in possession of drugs.

The Supreme Court ruling only applies to the possession of controlled substances. Other drug legislations in the state, such as the laws that govern the sale of drugs or driving under the influence, remain unaffected.

The Washington Association of Prosecuting Attorneys also sent a memo that directed its members to drop any ongoing drug possession cases.

Additionally, an official who is a member of the prosecutors’ group wrote an email to the Seattle Police Department stating that police officers should immediately stop arresting individuals for simple drug possession. This would also mean that police officers would not be allowed to search individuals or detain individuals while awaiting the arrival of canine units because they suspect said individuals of being in possession of drugs.

The email also noted that the police officers would need to be advised on whether they’d be permitted to seize any contraband or leave the drugs in the possession of the person in question.

The Washington Association of Sheriffs and Police Chiefs also conveyed guidelines to their members, which noted that under the law that was nullified by the state’s Supreme Court, law enforcement officers would no longer be allowed to seek a search warrant, carry out a criminal investigation, effect an arrest or take any other actions for the simple possession of controlled substances.

Pacific County Prosecutor Ben Haslam stated in an interview that the Supreme Court’s ruling had come as a surprise to the prosecutor’s office. Despite this, he added, the office was working on requesting the immediate release of persons who were currently being held in custody for simple possession.

He remarked that the prosecutor’s office would then move to revoke all active warrants on pending possession cases, going further to note that he expects that moving forward, the office would be required to vacate charges for persons who had been previously convicted of simple possession.

The decision passed down by Washington State’s Supreme Court may be seen as a good one by medical marijuana advocate because many companies are devoting their energies to developing therapeutic formulations from cannabis compounds. For instance, XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is set to begin clinical trials for its oral and sublingual strip of CBD, which is intended to treat forms of epilepsy that are nonresponsive to existing treatments.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Elon University Survey Finds North Carolina Residents Support Cannabis Legalization

Elon University conducted an online survey earlier this year, between Jan. 29 and Jan. 31, 2021. The university recently released the results of the statewide poll, which asked residents of North Carolina to share opinions on legalizing cannabis for various purposes.

More than 1,450 individuals provided feedback through the survey, which asked individuals to share their opinions on legalizing cannabis for recreational and medical use. The survey also asked individuals to share their views on how they perceived cannabis and how its legalization would impact society.

A similar poll on the views of North Carolina’s residents and the issues surrounding cannabis legalization had been conducted by Elon University earlier, in April 2017.

The results for this year’s poll are as follows: 17% of the individuals surveyed said that they did not support cannabis legalization for medical purposes while 73% did support medical use of cannabis. The proportion of individuals who did not support the change in policy has only changed slightly, with results from the 2017 survey showing that the percentage of those who opposed legalization of cannabis for medical use was 18%.

While the number of respondents in favor of legalizing recreational cannabis was lower than previous results, 54% of the respondents were still in favor of the legalization of recreational cannabis. This year’s poll showed that 34% of the respondents weren’t in favor of legalization of the recreational use cannabis. This is a significant decline as the 2017 survey had the number of those who were against recreational legalization of cannabis at 51%.

The survey also asked residents whether they were in favor of reducing penalties for cannabis possession from a criminal offense to a civil offense. The survey noted that 67% of the participants revealed that they supported a reduction of the penalty for cannabis possession.

The state of North Carolina has decriminalized the possession of small amounts of cannabis — but only for first offenses. It is possible for a first offense to be ruled as a suspended sentence. However, instead of a civil violation, the offense will carry the weight of a misdemeanor.

In addition to this, 64% of the survey participants admitted that legalizing cannabis would help the state’s economy; 45% of respondents also stated that crime rates would drop with the legalization of cannabis, although 31% were undecided on whether it would drop or increase.

Presently, 35 states in the United States have legalized cannabis for medical purposes and 15 states have legalized the use of marijuana for recreational purposes.

All states with legal medical marijuana programs are onto something because many companies have developed a number of cannabis-based medicines. A clear example is XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), which has been busy with drug formulation as well as drug delivery systems, including its CBD and THC combo sublingual strip targeting MS-induced spasticity.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Goldleaf Guided Journals: The Best for At-Home Marijuana Growers

If you have an obsession with buying notebooks, or just like them generally, and you also like and grow your own medical cannabis, then a Goldleaf guided journal may be perfect for you.

A Goldleaf guided journal is a minimalist notebook for marijuana home-growers as well asrecreational and medical users of the plant. Each journal comes with industry and medical advice supported by experts, ideal information for individuals who may be looking to deepen their understanding about the medicinal plant.

In particular, the grow planner adheres to marijuana farmers’ tradition of taking comprehensive notes to help compare the failures and successes of grows with time. This planner comes in a Moleskine-esque stylish design that has been tailored to suit the needs of intermediate and beginner marijuana home growers.

Charles McElroy, the founder of the company that makes Goldleaf planners, explained that the grow planner was suitable for individuals who would like to learn more about their craft. He added that Goldleaf’s intended customers were growers who were similar to him, describing himself as a self-confessed perfectionist who would like to learn from past errors and improve upon those mistakes.

This means that the journal wouldn’t be suitable for first-time marijuana growers or total beginners. However, beginners who would still like to use the Goldleaf Journal would have to conduct research on various soil-less growing methods as well as the basics of soil, light, nutrients and pH controls before they started growing.

Despite this, however, the grow journals are useful in helping growers keep track of their progress, if they have already made a decision on the different methods they’ll be using.

The grow journal comes in two types: the longer grow journal and the smaller grow jotter. While the latter is made up of two-page spreads for users to help track their plants’ nutrient regimens, a section for tracking cultivar particulars and templated day-to-day entry pages, the former is made up of these features, in addition to pages for tasting notes, a chart for plotting a plant’s health and month-to-month and yearly calendars.

Furthermore, when either journal is purchased, the owner receives a set of grower reference cards that contain tips on various things, such as how to diagnose a plant’s health issues or how to calculate how much energy is being used.

McElroy also explained that the idea behind Goldleaf was to find a way to show the science behind marijuana in a way that was more mature and digestible.

People who are growing their own medical cannabis may be glad to know that XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is set to conduct trials for a number of its cannabinoid-based treatments for spasticity linked to MS, Parkinson’s disease and other conditions.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.